NCT07702214

Brief Summary

this study will be conducted to Investigate the relationship between primary dysmenorrhea and biomechanical characteristics of lumbo-pelvic region among female university students

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
128

participants targeted

Target at P50-P75 for all trials

Timeline
4mo left

Started Jul 2026

Shorter than P25 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress2%
Jul 2026Dec 2026

First Submitted

Initial submission to the registry

July 9, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 14, 2026

Completed
16 days until next milestone

Study Start

First participant enrolled

July 30, 2026

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

July 14, 2026

Status Verified

July 1, 2026

Enrollment Period

4 months

First QC Date

July 9, 2026

Last Update Submit

July 9, 2026

Conditions

Keywords

Primary DysmenorrheaBiomechanical CharacteristicsLumbo-pelvic RegionFemale University Students

Outcome Measures

Primary Outcomes (1)

  • life disability

    The WaLIDD score (Working ability, Location, Intensity, and Days of pain) is a clinical questionnaire used to evaluate the severity of dysmenorrhea (painful menstruation) and to predict the likelihood of a person needing medical leave. It evaluates the condition using four criteria, each scored from 0 to 3, yielding a total possible score ranging from 0 to 12 points.Low/Mild Score (0 to 4 points): Indicates no dysmenorrhea.Moderate Score (5 to 7 points): Indicates moderate dysmenorrhea.High Score (8 to 12 points): Indicates severe dysmenorrhea.

    up to one day

Secondary Outcomes (8)

  • pain intensity

    up to one day

  • pelvic tilt angle

    up to one day

  • muscle activity

    up to one day

  • oscillatory frequency

    up to one day

  • muscle dynamic stiffness

    up to one day

  • +3 more secondary outcomes

Study Arms (2)

Females with primary dysmenorrhea

64 females with primary dysmenorrhea will participate in this group, neumerical rating scale more than 4.

Other: Females with primary dysmenorrhea

Females without dysmenorrhea

64 females without dysmenorrhea will participate in this group. neumerical rating scale less than 3

Other: Females without dysmenorrhea

Interventions

Female university students aged 18-24 years, Body Mass Index (BMI) between 18.5 and 24.9 kg/m² with primary dysmenorrhea (NRS \> 4).

Females with primary dysmenorrhea

Female university students aged 18-24 years, with a Body Mass Index (BMI) between 18.5 and 24.9 kg/m² without dysmenorrhea (NRS less 3).

Females without dysmenorrhea

Eligibility Criteria

Age18 Years - 24 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility Details128 Female university students aged 18-24 years, Body Mass Index (BMI) between 18.5 and 24.9 kg/m² will be participated in this study
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

128 female university students aged 18-24 years with a Body Mass Index (BMI) between 18.5 and 24.9 kg/m² will participate in this study. The female will be allocated to groups depending on the level of NRS, more than 4 will be in the dysmenorrhea group, and less than 3 will be in the non-dysmenorrhea group.

You may qualify if:

  • Female university students aged 18-24 years
  • Body Mass Index (BMI) between 18.5 and 24.9 kg/m²
  • Regular menstrual cycle (28-35 days) for at least the past six months
  • Willingness to avoid analgesics 72 hours prior to testing

You may not qualify if:

  • History of pelvic or gynecological disorders
  • Previous spinal, abdominal, or lower limb surgery
  • Neurological disorders
  • Structural spinal deformities (e.g., moderate to severe scoliosis)
  • Obesity (BMI ≥ 30 kg/m²)
  • Current use of oral contraceptive pills
  • History of pregnancy or delivery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Central Study Contacts

Aya Hassanein, master

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principle investigator : Aya khalifa mohamed

Study Record Dates

First Submitted

July 9, 2026

First Posted

July 14, 2026

Study Start

July 30, 2026

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

July 14, 2026

Record last verified: 2026-07